Detalles de la búsqueda
1.
Regional differences in outcomes with ablation versus drug therapy for atrial fibrillation: Results from the CABANA trial.
Am Heart J
; 270: 103-116, 2024 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-38307365
2.
Ten years of subcutaneous defibrillator therapy: Consolidated clinical evidence and future perspectives.
J Cardiovasc Electrophysiol
; 35(3): 601-607, 2024 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-38287171
3.
Metabolic disorders affecting the liver and heart: Therapeutic efficacy of miRNA-based therapies?
Pharmacol Res
; 201: 107083, 2024 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-38309383
4.
A Single-lead ECG algorithm to differentiate right from left manifest accessory pathways: A reappraisal of the P-Delta interval.
J Cardiovasc Electrophysiol
; 34(3): 598-606, 2023 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-36640425
5.
Catheter-induced right bundle branch block: Practical implications for the cardiac electrophysiologist.
J Cardiovasc Electrophysiol
; 34(11): 2316-2329, 2023 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-37655997
6.
Catheter ablation of left atrial tachycardia adjacent to a septal closure device: A multifaceted challenge?
Pacing Clin Electrophysiol
; 46(10): 1230-1234, 2023 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-36788778
7.
How much does the presentation pattern of atrial fibrillation affect thrombo-embolic risk and mortality?
Eur Heart J Suppl
; 25(Suppl B): B46-B49, 2023 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-37091643
8.
Air entrapment as a potential cause of early subcutaneous implantable cardioverter defibrillator malfunction: a systematic review of the literature.
Europace
; 24(10): 1608-1616, 2022 10 13.
Artículo
en Inglés
| MEDLINE | ID: mdl-35639806
9.
The many NOs to the use of Class IC antiarrhythmics: weren't the guidelines too strict?
Eur Heart J Suppl
; 24(Suppl I): I47-I53, 2022 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-36380776
10.
Predictors of sinus rhythm 6 weeks after cardioversion of atrial fibrillation: a pre-planned post hoc analysis of the X-VeRT trial.
Europace
; 23(10): 1539-1547, 2021 10 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-34128075
11.
Periprocedural anticoagulation in the uninterrupted edoxaban vs. vitamin K antagonists for ablation of atrial fibrillation (ELIMINATE-AF) trial.
Europace
; 23(1): 65-72, 2021 01 27.
Artículo
en Inglés
| MEDLINE | ID: mdl-33249467
12.
How effective is cryoablation in the treatment of atrial fibrillation?
Eur Heart J Suppl
; 23(Suppl E): E51-E54, 2021 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-34650354
13.
Stroke and mortality risk after atrial fibrillation ablation: lesson from the CABANA trial.
Eur Heart J Suppl
; 22(Suppl L): L38-L40, 2020 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-33239978
14.
Atrial fibrillation ablation in heart failure.
Eur Heart J Suppl
; 22(Suppl E): E50-E53, 2020 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-32523439
15.
Uninterrupted edoxaban vs. vitamin K antagonists for ablation of atrial fibrillation: the ELIMINATE-AF trial.
Eur Heart J
; 40(36): 3013-3021, 2019 09 21.
Artículo
en Inglés
| MEDLINE | ID: mdl-30976787
16.
[Recommendations for the management of COVID 19 patients regarding proarrhythmic effects of some current treatments, specifically if these patients suffer from arrhythmias, and for those receiving antiarrhythmic therapy.]
Kardiologiia
; 60(10): 4-12, 2020 Sep 16.
Artículo
en Ruso
| MEDLINE | ID: mdl-33228499
17.
[Recommendations of the Eurasian Arrhythmology Association (EURA) for the diagnosis and treatment of patients with arrhythmias and conduction disorders during the COVID-19 pandemic].
Kardiologiia
; 60(5): 4-8, 2020 May 04.
Artículo
en Ruso
| MEDLINE | ID: mdl-32515698
18.
Journal of Cardiovascular Electrophysiology special section: The European Cardiac Arrhythmia Society 2023 meeting.
J Cardiovasc Electrophysiol
; 35(3): 520-521, 2024 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-38314501
19.
Concise guidelines of the European Cardiac Arrhythmias Society (ECAS) on "catheter ablation of atrial fibrillation": A prepublication of the methods in preparation of the final guidelines document.
J Cardiovasc Electrophysiol
; 2024 May 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-38736156
20.
Open Issues in the Management of Otcagerian Patients with Atrial Fibrillation and Chronic Kidney Disease: Are we Ready for Left Atrial Appendage Occlusion (LAAO) as First-Line Therapy for Thromboembolic Risk Prevention?
Cardiovasc Drugs Ther
; 38(3): 401-403, 2024 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-38277064